A group of Mater Researchers have reimagined the traditional model of care for pregnant women who are diagnosed with gestational diabetes mellitus (GDM), saving patients both time and money during...
During Men’s Health Week 2023, Mater Research is shining a ‘fluorescent’ light on the work being done by researchers to improve the surgical and medical treatment options for men with prostate...
Mater Research Occupational Therapy PhD student Aleysha Martin, who recently returned from a five-week industry placement at the Royal College of Occupational Therapists (RCOT) in London.
Dr John Kemp is widely recognised as an expert in the field of osteoporosis genomics, and he now brings this expertise to Mater Research as the Group Leader of the Musculoskeletal Genomics Group.
An Ipswich mum diagnosed with stage three bowel cancer nearly 12 weeks after having her second child is warning young people that ‘cancer doesn’t discriminate’.
Loretta Weatherall is a proud Gamilaraay woman, who has spent over 10 years delivering and promoting education and health programs in First Peoples communities.
Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.
Stephanie Guilas has worked in many departments throughout Mater Hospital Brisbane, however, after 28 years of service, she found her true passion working within Mater Research’s Mothers and Babies...
Families who have experienced the loss of an unborn baby or fertility problems are being given new hope of becoming parents thanks to cutting-edge research funded by a $500,000 donation from The...
Working as a research assistant in an immunology research lab, Yvonne Gautam learnt what a clinical trial was after being asked to set up a lab for a Phase Two clinical trial.
In late-October 2022, 66-year-old retiree Susan was diagnosed with Stage 3 serous ovarian cancer. Susan said that once she was diagnosed, everything moved very quickly.
Mater Clinical Trial Coordinator Georgie Huggett spent more than 10 years working in palliative care oncology before accepting what was supposed to be a temporary role with Mater Research.